The role of IgA in primary biliary cirrhosis.

被引：0
|
作者：
Fukushima, N
Nalbandian, G
Van de Water, J
White, K
Ansari, AA
Kenny, TP
Kamita, SG
Hammock, BD
Coppel, RL
Stevenson, F
Ishibashi, H
Gershwin, ME
机构：
[1] Univ Calif Davis, Davis, CA 95616 USA
[2] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
[4] Monash Univ, Clayton, Vic 3168, Australia
[5] Southampton Univ Hosp Trust, Southampton, Hants, England
[6] Natl Nagasaki Med Ctr, Nagasaki, Japan
[7] Univ Calif Davis, Davis, CA 95616 USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1332
引用
收藏
页码：496A / 496A
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of ursodeoxycholic acid in primary biliary cirrhosis.
    Pasha, TM
    Heathcote, J
    CauchDudek, K
    Therneau, T
    Dickson, ER
    Gabriel, S
    Lindor, KD
    HEPATOLOGY, 1996, 24 (04) : 169 - 169
  • [42] Conjugated bilirubin is an accurate marker of cholestasis in primary biliary cirrhosis.
    Crosignani, A
    Muraca, M
    Longo, M
    Battezzati, PM
    Invernizzi, P
    Zermiani, P
    Vilei, MT
    Mingardi, M
    Perego, F
    Meda, F
    Podda, M
    GASTROENTEROLOGY, 2000, 118 (04) : A900 - A900
  • [43] Caspase 8 gene polymorphism is associated with primary biliary cirrhosis.
    Perrow, KA
    Taylor, JJ
    James, O
    Bassendine, M
    Jones, D
    Donaldson, P
    HEPATOLOGY, 2002, 36 (04) : 417A - 417A
  • [44] Application of aberrant cytokeratin expression for staging of primary biliary cirrhosis.
    Yamamoto, K
    Yabushita, K
    Ibuki, N
    Okamoto, R
    Matsumura, S
    Okano, N
    Shimada, N
    Tsuji, T
    HEPATOLOGY, 1999, 30 (04) : 565A - 565A
  • [45] Hyperlipidemic state and cardiovascular risk in course of primary biliary cirrhosis.
    Longo, M
    Crosignani, A
    Battezzati, PM
    Invernizzi, P
    Squarcia, C
    Pipia, C
    Colombo, L
    Colombo, A
    Dosio, S
    Perego, F
    Meda, F
    Podda, M
    GASTROENTEROLOGY, 2000, 118 (04) : A1008 - A1008
  • [46] Risk factors for sudden cardiac death in primary biliary cirrhosis.
    Newton, JL
    Bhalla, N
    Jones, DE
    HEPATOLOGY, 2004, 40 (04) : 462A - 462A
  • [47] Isolation and characterization of a novel virus associated with primary biliary cirrhosis.
    Xu, LH
    Guo, L
    Keogh, A
    Joplin, R
    Shen, ZW
    Peng, XC
    Neuberger, J
    Mason, A
    HEPATOLOGY, 2000, 32 (04) : 297A - 297A
  • [48] Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis.
    Kawamura, K
    Kageyama, F
    Kobayashi, Y
    Kawasaki, T
    Toyokuni, S
    Uchida, K
    HEPATOLOGY, 1999, 30 (04) : 543A - 543A
  • [49] Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis.
    Selmi, C
    Ross, SR
    Ansari, AA
    Invernizzi, P
    Podda, M
    Coppel, RL
    Gershwin, ME
    HEPATOLOGY, 2004, 40 (04) : 207A - 207A
  • [50] Hydroxylysylpyridinoline as a marker for fibrotic activity in primary sclerosing cholangitis and primary biliary cirrhosis.
    Gillessen, A
    Acil, Y
    Ruppert, K
    Henning, B
    HEPATOLOGY, 2001, 34 (04) : 526A - 526A
12345